These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience. Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320 [TBL] [Abstract][Full Text] [Related]
29. Hypersensitivity vasculitis related to aceclofenac. Morros R; Figueras A; Capella D; Laporte JR Br J Rheumatol; 1997 Apr; 36(4):503-4. PubMed ID: 9159552 [No Abstract] [Full Text] [Related]
30. Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis. Pareek A; Chandurkar N Curr Med Res Opin; 2013 Jul; 29(7):849-59. PubMed ID: 23581533 [TBL] [Abstract][Full Text] [Related]
31. Hepatotoxicity to several nonsteroidal anti-inflammatory drugs with diclofenac induced histological changes. Adebajo AO; Eastmond CJ Clin Rheumatol; 1992 Mar; 11(1):120-1. PubMed ID: 1582111 [No Abstract] [Full Text] [Related]
32. [Acute hepatitis after use of nimesulide: drug-induced or is there something more? Mononucleosis]. Quadranti P Praxis (Bern 1994); 2004 Oct; 93(43):1785-7. PubMed ID: 15553900 [No Abstract] [Full Text] [Related]
33. Non-pigmenting Fixed Drug Eruption: An Unusual Adverse Reaction to Aceclofenac. Prabha N; Chhabra N Curr Drug Saf; 2018; 13(3):224-225. PubMed ID: 30047334 [TBL] [Abstract][Full Text] [Related]
34. Elevated Transaminases with Topical Diclofenac: A Case Report. Daniels AM; Gibbs LM; Herndon CM J Pain Palliat Care Pharmacother; 2018; 32(2-3):161-164. PubMed ID: 30645151 [TBL] [Abstract][Full Text] [Related]
35. [Hepatitis secondary to current non-steroidal anti-inflammatory agents]. Hannequin JR; Doffoel M; Schmutz G Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):983-8. PubMed ID: 3070713 [TBL] [Abstract][Full Text] [Related]
36. [Toxic hepatitis caused by bendazac]. Prieto de Paula JM; Cancelo Suárez P; Villamandos Nicás V; Sánchez Sánchez A Med Clin (Barc); 1993 May; 100(20):798. PubMed ID: 8321062 [No Abstract] [Full Text] [Related]
37. [Hepatitis due to pirprofen; 3 cases, 1 fatality]. Fouin-Fortunet H; Lerebours E; Bernet J; Hemet J; Colin R Ann Gastroenterol Hepatol (Paris); 1986; 22(1):23-5. PubMed ID: 2938537 [TBL] [Abstract][Full Text] [Related]
38. Lumiracoxib-induced cholestatic liver injury. Fok KC; Bell CJ; Read RB; Eckstein RP; Jones BE Intern Med J; 2013 Jun; 43(6):731-2. PubMed ID: 23745998 [No Abstract] [Full Text] [Related]
39. Lessons from Lumiracoxib: are cyclooxygenase-2 inhibitors less hepatotoxic than non-selective non-steroidal anti-inflammatory drugs? Chitturi S; Farrell GC J Gastroenterol Hepatol; 2012 Jun; 27(6):993-4. PubMed ID: 22621454 [No Abstract] [Full Text] [Related]
40. [Hepatitis caused by non-steroidal anti-inflammatory agents. A cooperative evaluation of regional centers of drug surveillance for 1985]. Castot A; Netter P; Larrey D; Carlier P; Gaire M; Bannwarth B Therapie; 1988 May; 43(3):229-33. PubMed ID: 3420570 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]